title: Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2.
abstract: Angiopoietin-2 (Ang2) exhibits broad expression in the remodeling vasculature of human tumors but very limited expression in normal tissues, making it an attractive candidate target for antiangiogenic cancer therapy. To investigate the functional consequences of blocking Ang2 activity, we generated antibodies and peptide-Fc fusion proteins that potently and selectively neutralize the interaction between Ang2 and its receptor, Tie2. Systemic treatment of tumor-bearing mice with these Ang2-blocking agents resulted in tumor stasis, followed by elimination of all measurable tumor in a subset of animals. These effects were accompanied by reduced endothelial cell proliferation, consistent with an antiangiogenic therapeutic mechanism. Anti-Ang2 therapy also prevented VEGF-stimulated neovascularization in a rat corneal model of angiogenesis. These results imply that specific Ang2 inhibition may represent an effective antiangiogenic strategy for treating patients with solid tumors.
authors.affiliation: Amgen, Thousand Oaks, California 91320, USA. joliner@amgen.com
authors.forename: Jonathan
authors.initials: J
authors.lastname: Oliner
authors.forename: Hosung
authors.initials: H
authors.lastname: Min
authors.forename: Juan
authors.initials: J
authors.lastname: Leal
authors.forename: Dongyin
authors.initials: D
authors.lastname: Yu
authors.forename: Shashirekha
authors.initials: S
authors.lastname: Rao
authors.forename: Edward
authors.initials: E
authors.lastname: You
authors.forename: Xiu
authors.initials: X
authors.lastname: Tang
authors.forename: Haejin
authors.initials: H
authors.lastname: Kim
authors.forename: Susanne
authors.initials: S
authors.lastname: Meyer
authors.forename: Seog Joon
authors.initials: SJ
authors.lastname: Han
authors.forename: Nessa
authors.initials: N
authors.lastname: Hawkins
authors.forename: Robert
authors.initials: R
authors.lastname: Rosenfeld
authors.forename: Elyse
authors.initials: E
authors.lastname: Davy
authors.forename: Kevin
authors.initials: K
authors.lastname: Graham
authors.forename: Frederick
authors.initials: F
authors.lastname: Jacobsen
authors.forename: Shirley
authors.initials: S
authors.lastname: Stevenson
authors.forename: Joanne
authors.initials: J
authors.lastname: Ho
authors.forename: Qing
authors.initials: Q
authors.lastname: Chen
authors.forename: Thomas
authors.initials: T
authors.lastname: Hartmann
authors.forename: Mark
authors.initials: M
authors.lastname: Michaels
authors.forename: Michael
authors.initials: M
authors.lastname: Kelley
authors.forename: Luke
authors.initials: L
authors.lastname: Li
authors.forename: Karen
authors.initials: K
authors.lastname: Sitney
authors.forename: Frank
authors.initials: F
authors.lastname: Martin
authors.forename: Ji-Rong
authors.initials: JR
authors.lastname: Sun
authors.forename: Nancy
authors.initials: N
authors.lastname: Zhang
authors.forename: John
authors.initials: J
authors.lastname: Lu
authors.forename: Juan
authors.initials: J
authors.lastname: Estrada
authors.forename: Rakesh
authors.initials: R
authors.lastname: Kumar
authors.forename: Angela
authors.initials: A
authors.lastname: Coxon
authors.forename: Stephen
authors.initials: S
authors.lastname: Kaufman
authors.forename: James
authors.initials: J
authors.lastname: Pretorius
authors.forename: Sheila
authors.initials: S
authors.lastname: Scully
authors.forename: Russ
authors.initials: R
authors.lastname: Cattley
authors.forename: Marc
authors.initials: M
authors.lastname: Payton
authors.forename: Steve
authors.initials: S
authors.lastname: Coats
authors.forename: Linh
authors.initials: L
authors.lastname: Nguyen
authors.forename: Binodh
authors.initials: B
authors.lastname: Desilva
authors.forename: Anthony
authors.initials: A
authors.lastname: Ndifor
authors.forename: Isaac
authors.initials: I
authors.lastname: Hayward
authors.forename: Robert
authors.initials: R
authors.lastname: Radinsky
authors.forename: Tom
authors.initials: T
authors.lastname: Boone
authors.forename: Richard
authors.initials: R
authors.lastname: Kendall
mesh_terms: D042702:Angiopoietin-2 / Q000037:antagonists & inhibitors* / Q000276:immunology*; D000818:Animals; D000906:Antibodies / Q000494:pharmacology*; D049109:Cell Proliferation / Q000187:drug effects; D003315:Cornea / Q000098:blood supply; D042783:Endothelial Cells / Q000187:drug effects; D005260:Female; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000517:prevention & control*; D009500:Neutralization Tests; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D042702:Angiopoietin-2; D000906:Antibodies; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins